Delivery Order SPE2DB22D3016-SPE2DB26FABS6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Naltrexone 50 mg tablets in quantities of 60 units. This competitively awarded, non-set-aside contract has a ceiling value of $3,275.92 and is structured as a firm fixed-price delivery order with a completion date of November 5, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Naltrexone 50 mg tablets (100-count units) with a contract ceiling value of $1,700.58. This firm fixed-price delivery order, which is set to be completed by October 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $40,872.08 to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets in quantities of 60 units. The contract, awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division and performed work...
- The Defense Logistics Agency awarded a $2,397.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets (100-count units), with an ultimate completion date of June 2, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor's Corporate Office located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $22,997.98 for Naltrexone 50 mg tablets (60-count) on January 29, 2025, with completion expected by January 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a $3,524.80 delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Naltrexone 50 mg tablets (60-count units), with completion scheduled for November 4, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Naltrexone 50 mg tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $1,782.75, represents a non-competitive, non-set-aside award with an ultimate completion date of July 25, 2025. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Naltrexone 50 mg tablets in quantities of 60 units, with a ceiling value of $12,745.23. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Logistics Agency (DLA) awarded a $29,831.08 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp. to supply 60-count Naltrexone 50 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which enables DLA to efficiently procure a wide range of pharmaceutical and medical supplies to support military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor, holds...
- The Defense Logistics Agency awarded a delivery order valued at $6,596.61 to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets (100-count units) with a firm fixed price structure. The contract, which became effective on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a non-competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FABS6Delivery Order
The Defense Logistics Agency (DLA) awarded a $2,744.80 delivery order to AmerisourceBergen Drug Corp for Naltrexone 50 mg tablets (100-count units) with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a standard pharmaceutical procurement supporting federal medical supply requirements. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company serves as a critical vendor for the Defense Health Agency and other federal healthcare systems, with its contract portfolio demonstrating extensive experience fulfilling diverse pharmaceutical needs across multiple therapeutic domains for military and veteran populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 11/7/25 |